uBriGene Biosciences Submits Drug Master File for iPSC Reprogramming mRNA-LNP Kit
Faster Clinical Translation and Commercialization of Therapies Derived From iPSC Technology GERMANTOWN, MARYLAND / ACCESS ...
uBriGene Biosciences Inc.: uBriGene Biosciences Submits Drug Master File for iPSC Reprogramming mRNA-LNP Kit
Faster Clinical Translation and Commercialization of Therapies Derived From iPSC Technology GERMANTOWN, MARYLAND / ACCESS Newswire / March 4, 2025 / uBriGene Biosciences (uBriGene), a leading cell and ...